As Chairman of the Board, Dr. Winkenwerder led the proceedings of the C-Change Annual Meeting held October 5th through 7th at the Capitol Hilton Hotel in Washington, DC. The meeting agenda which involved many of the nation’s healthcare leaders addressed new strategies for improving America’s health and ways the healthcare system must be transformed to improve cancer care.
Speakers and discussants included Kathleen Sebelius, Secretary of U.S. Department of Health and Human Services; Donald Berwick, MD, MPP, Administrator at the Centers for Medicine and Medicaid Services; Allen Lichter, MD, President of the American Society of Clinical Oncology; Howard Koh, MD, Assistant Secretary for Health, U.S. Department of Health and Human Services; Alice Rivlin, PhD, Senior Fellow, The Brookings Institute; and Douglas Holtz-Eakin, President of the American Action Forum and former Director of the Congressional Budget Office.
Leaders of the U.S. cancer community gathered at this annual session to coordinate their efforts and activities with the aim of preventing and reducing the rates of cancer, improving cancer therapies and survival, and enhancing the value of cancer car.
C-Change is a non-profit organization whose purpose is the elimination of cancer as a major public health problem at the earliest possible time. C-Change leverages the leadership and expertise of all major organizations in America involved in the fight against cancer. Among its members are The American Cancer Society, The Susan G. Komen Foundation, The Lance Armstrong Foundation, Sloan Kettering Cancer Center, MD Anderson Cancer Center, GlaxoSmithKline, Merck, Pfizer, Novartis and many other pharmaceutical firms, Aetna, CDC, National Cancer Institute and numerous others. If you would like further information on C-Change click here.